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execution: six needles were inserted, to cover the lesion with adequate safety margin to account for microscopic spread. Needles
were planned and inserted according to the rules of the Paris System. 7. Plastic tube overinsertion: plastic tubes were overinserted
into the hollow needles. Needles were then removed and the plastic tubes rested in place. 8. Evaluation of the implant: to assess
if additional tubes are needed for adequate target coverage. 9. Fixation of the tubes with plastic buttons to the skin of the patient.
10. Under the supervision of the anesthesiologist, the patient goes to the CT-room under general anesthesia in order to facilitate
the obtention of CT images to calculate the treatment plan. The patient then goes to the recovery room or ICU according to the
anesthesiologist criteria. 11. Treatment plan is calculated by the medical physicist from CT images. The radiation oncologist
prescribe the dose and accept the plan. 12. After QA procedures are cleared the patient starts treatment.
Conclusion. Interstitial HDR brachytherapy for tongue cancer is a feasible technique. Adequate training is needed to acquire the
needed skills to implement this technique in a general hospital.
http://dx.doi.org/10.1016/j.rpor.2013.03.663
Intraoperative high dose rate brachytherapy (HDR-IORT) in locally advanced rectal cancer
E. Villafranca, P. Romero, F. Arias, A. Sola, C. Eito, M. Errasti, M. de Miguel, P. Armendariz, M. Ciga, F. Oteiza
Complejo Hospitalario De Navarra, Radiation Oncology and Surgery, Spain
The risk of developing local recurrence after treatment of a primary rectal cancer increases with increased stage. Treatment of
early-stage rectal cancer with preoperative radiotherapy (RT) and total mesorectal excision result in a local recurrence of 6% for
Stage II and 15% for Stage III tumors. Survival after recurrence depends on stage and treatment and this result in a 3-year survival
rate varying from 0% to 60%. Intraoperative radiotherapy is used to increase dose of Radiation and decrease local recurrence. Two
techniques can be used: intraoperative electron beam radiotherapy (IOERT) and high-dose-rate brachytherapy (HDR-IORT). The
ﬂexible template inHDR-IORT can treat all surfaces. Centers use a 1-cm-thick applicator as a template and often prescribed a dose
of 15Gy at the surface or 10Gy at 0.5 cm depth from the surface of the applicator. The HDR-IORT procedure consists of placing a
ﬂat ﬂexible applicator of a centimeter of thickness, in whose interior there are several placed catheters supporting parallelism
and separation of 1 cm. The applicator is placed in the tumor bed marked with clips, for what is necessary the collaboration of
the surgeons. Later, a 2D planning is realized and patient is translated to the unit of brachytherapy near the operating room.
Our series includes 7 patients treated between 2010 and 2012. Doses: 10Gy to 1 cm of the catheters. Results: pathologic stages:
pT0-mic: 2 p, pT3: 3p, pT4: 2p; distance to the surgical margin: 0–4mm. Failures: local 0p, metastases 2p. Situation at the last
review: 1p death with disease, 1p life with disease, 5p life without disease. In the video we can see a case report of a patient with
locally advanced primary rectal cancer treated with HDR-IORT after preoperative chemoradiotherapy.
http://dx.doi.org/10.1016/j.rpor.2013.03.664
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Introduction. The prostate cancer is themost frequent tumor inmen; the brachytherapy is an alternative treatment highly effective
and tolerable.
Abstract. In May 2011 we have launched LDR brachytherapy technique in our unit, indicated for low risk prostate cancer patients.
Personal: Radiation oncologist, physicist, urologist, anesthetist, nurse, auxiliary nursing and radiation technical. Patient settled
in lithotomy position with spinal anesthesia and urinary catheter.
Procedure. – Positione the endorectal ultrasound image, visualize the prostate in transverse and longitudinal cuts, do the vol-
umetric reconstruction and draw structures (prostate, urethra and rectum). – Perform preplanning dosimetry and check PTV
and OAR dose. – Insert transperineal needles and verify the dosimetric parameters. – Place “seed-selectron”, release the seeds
automatically and remove the needles. – Make cystoscopy to sure that no seeds in bladder and test that there isn’t hematuria.
http://dx.doi.org/10.1016/j.rpor.2013.03.665
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Purpose. Brachytherapy allows delivering higher doses of radiation to more-speciﬁc areas of the body, compared with the conven-
tional form of radiation therapy (external beam radiation). This allows being very effective in tumor control and not damaging
